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Utility of pulse wave velocity and pulse wave 
analysis in assessment of hypertensive 
target organ damage in children with primary 
hypertension
Przydatność pomiarów prędkości fali tętna oraz analizy fali tętna w ocenie powikłań 
narządowych u dzieci z nadciśnieniem tętniczym pierwotnym
Streszczenie
Wstęp Sztywność ścian naczyń, określana pomiarem pręd­
kości fali tętna (PWV), jest uważana za marker uszkodzenia 
narządowego u dorosłych z nadciśnieniem tętniczym. Ana­
liza fali tętna (PWA) umożliwia ocenę centralnego ciśnienia 
tętniczego, wstecznej fali tętna, rzutu serca oraz całkowite­
go oporu obwodowego. Brak jednak danych dotyczących 
przydatności wyżej wymienionych pomiarów w  ocenie 
ryzyka powikłań narządowych u  dzieci z  nadciśnieniem 
tętniczym.
Celem badania było określenie związku między PWV 
i PWA a ustalonymi markerami uszkodzenia narządowego 
(wskaźnikiem masy lewej komory serca — LVMI, grubo­
ścią kompleksu błona środkowa–błona wewnętrzna tętnicy 
szyjnej wspólnej — cIMT, polem przekroju tętnicy szyjnej 
— WCSA) u  dzieci z  nieleczonym nadciśnieniem tętni­
czym pierwotnym.
Materiał i metody W badaniu wzięło udział 95 pacjentów 
(14,9 ± 2,5 roku; 23 dziewczynki), skierowanych z podej­
rzeniem nadciśnienia tętniczego pierwotnego, u  których 
wykluczono wtórne postaci nadciśnienia tętniczego. Pręd­
kość fali tętna i analiza fali tętna były mierzone przy użyciu 
funkcji oscylometrycznej aparatu Vicorder. PWV i cIMT 
były wyrażane w wartościach absolutnych oraz w  formie 
odchylenia standardowego (SDS) — uwzględniając nie­
dawno opublikowane wartości referencyjne.
Wyniki Spośród 95 pacjentów skierowanych z podwyższo­
nym ciśnieniem tętniczym i poddanych pełnemu procesowi 
diagnostycznemu u  32 stwierdzono prawidłowe wartości 
ciśnienia tętniczego, u  12 stan przednadciśnieniowy, u  7 
ambulatoryjne nadciśnienie tętnicze, u 44 ciężkie ambula­
toryjne nadciśnienie tętnicze. Pacjenci z  przerostem lewej 
komory serca (LVH) mieli znacząco większe skurczowe ciś­
nienie tętnicze w  ciągu doby, jak również ciśnienie tętna, 
cIMT i WCSA w porównaniu z pacjentami bez LVH. Nie 
obserwowano różnic w PWV, wskaźniku augmentacji (Au­
gIndex), ciśnieniu augmentacji (AugPress) oraz CBP między 
pacjentami z  LVH i/lub z  cIMT > 2SDS, a  pacjentami 
z cIMT < 2SDS i prawidłowym LVMI. Porównanie mię­
dzy grupami, określonymi na podstawie wartości ciśnienia 
tętniczego, wykazało znacząco większe AugPree i AugIndex 
w  grupie z  ciężkim ambulatoryjnym nadciśnieniem tętni­
czym w porównaniu z pozostałymi trzema grupami. Grupy 
te nie różniły się pod względem PWV. Wartość prędkości 
fali tętna była skorelowana ze stężeniem kwasu moczowego 
(p = 0,001; r = 0,357) oraz stężeniem cholesterolu LDL 
(p = 0,01; r = 0,242), jednak nie z TOD. AugPress i AugIn­
dex korelowały ze stężeniem trójglicerydów (odpowiednio 
p = 0,003; r = 0,307 i p = 0,002; r = 0,319) i LVMI (od­
powiednio p = 0,03; r = 0,206 i p = 0,03; r = 0,242. Na 
podstawie regresji krokowej wykazano, że jedynymi pre­
dyktorami LVMI są wartość wskaźnika augmentacji oraz 
ciśnienie skurczowe w ciągu doby (R2 = 0,095; B = 0,308; 
p = 0,006 i R2 = 0,142; AugIndex: B = 0,280; p = 0,011; 
ABPM SBP: B = 0,218; p = 0,047). Copyright © 2014 Via Medica, ISSN 1428–5851
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Wnioski U dzieci z nadciśnieniem tętniczym pierwotnym 
wykazano zależność między kategorią nadciśnienia tętnicze­
go, centralnym ciśnieniem tętniczym, wskaźnikiem augmen­
tacji oraz ciśnieniem augmentacji a przerostem lewej komory 
serca. Ustalono, iż prędkość fali tętna nie koreluje z LVH, 
ma natomiast związek z biochemicznymi czynnikami ryzy­
ka uszkodzenia narządowego. Brak bezpośredniego związku 
między wartościami PWV a  uszkodzeniem narządowym 
może być spowodowany stosunkowo niewielkim zwiększe­
niem wartości ciśnienia tętniczego oraz krótkim czas jego 
trwania u dzieci z nadciśnieniem tętniczym pierwotnym.
słowa kluczowe: sztywność naczyń, prędkość fali tętna, 
centralne ciśnienie tętnicze, uszkodzenie narządowe
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Background
Arterial stiffness and its hemodynamic consequ­
ences are established to be the main predictors of 
adverse cardiovascular outcomes. During aging and 
progression of cardiovascular disease, central elastic 
arteries become stiffer, diastolic pressure decreases, 
and central systolic blood pressure (sCBP) and pul­
se pressures are augmented due to increased pulse 
wave velocity (PWV). Recently, several parameters 
of arterial stiffness have been employed and have 
given some valuable information about arterial wall 
properties. Among these, PWV and central blood 
pressure (CBP) are the parameters which have gained 
the most attention, and its predictive accuracy has 
been demonstrated in a number of studies [1–8]. 
They are positively associated with arterial hyperten­
sion, coronary artery disease, stroke, heart failure and 
survival in dialysed patients [9–12]. Moreover, an 
increased PWV was also added to the list of markers 
of subclinical target organ damage and prognostic 
factors in the European Guidelines for management 
of arterial hypertension in adults [13, 14]. However, 
there are only few reports on PWV and CBP in hy­
pertensive children. Thus, the aim of our study was 
to evaluate arterial stiffness markers in the early sta­
ges of cardiovascular disease in children with newly 
diagnosed primary hypertension (PH).
Material and methods
The study was performed according to the Dec­
laration of Helsinki and with the approval of the 
Children’s Memorial Health Institute Ethics Com­
mittee. All patients (pts) and parents gave consent to 
participate in the study. 
Ninety­five patients (age; 15.3 years, range; 13.3–
–17.3 years; 27 girls) with newly diagnosed and untre­
ated primary hypertension, who underwent full dia­
gnostic approach to exclude secondary hypertension, 
were included to the study. The exclusion criteria 
were the following: the presence of any significant 
chronic disease (except for PH) including diabetes 
mellitus and chronic kidney disease, any acute illness 
including infections in the 6 weeks preceding enrol­
ment, and incomplete data. 
PH was diagnosed according to The Fourth Task 
Force Report and European Society of Hypertension 
guidelines and confirmed by 24­hour ambulatory BP 
monitoring (ABPM) [15, 16]. Blood pressure (BP) 
status was defined according to the ambulatory blood 
pressure measurement classification [17]. 
ABPM measurements
All ABPM measurements were assessed oscillo­
metrically using SpaceLabs Monitor 90207, and the 
most appropriate cuff was applied on the non­do­
minant arm. Readings were taken every 20 minutes 
during daytime and every 30 minutes at night. Re­
cordings lasting ≥ 20 hours with ≥ 80% of readings 
were considered as valid and were included in the 
analysis. We used a recently published classification 
system based on ABPM to classify patients as having 
normal BP, ambulatory hypertension, and severe am­
bulatory hypertension [17, 18].
Measurement of carotid to femoral PWV
The Vicorder system provides a simple and quick 
non­invasive oscillometric method of obtaining the 
Pulse Wave Velocity for an arterial segment. Measu­
rement was performed in the supine position after 
5 minutes of rest using the Vicorder device according 
to the actual guidelines [19]. A 100­mm wide BP cuff 
was placed around the right upper thigh to measu­
re the femoral pulse wave and a 30­mm plethysmo­
graphic partial inflatable sensor was placed over the 
carotid region, able to pick up the carotid pulse wave. 
Both cuffs are automatically inflated to 65mmHg and 
the corresponding oscillometric signal from each cuff 
is digitally analysed using the latest patented technique 
to accurately extract, in real time, the pulse time delay 
and the consequent Pulse Wave Velocity.
Measurement of central blood pressure (pulse 
wave analysis)
The Vicorder device analyses the waveform of radial 
artery pulse obtained oscillometrically and then using 
transfer function calculates the aortic waveform. Prior 
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to the measurement it was necessary to enter the 
individual features and the value of blood pressure 
measured at the brachial artery. System after the 
measurement calculates and presents approximated 
waveform of the aortic valve, which we can acquire 
a number of parameters describing the characteristics 
of the arterial system including aortic (central) blood 
pressure (CBP), augmentation pressure (Aug Press), 
augmentation index (AugIndex), aortic pulse pressu­
re (AoPP), cardiac output (CO) and total peripheral 
resistance index (TPRI) [19–21].
Echocardiography
All echocardiography examinations were performed 
by 1 examiner who knew the clinical diagnosis, but 
was not aware of the severity of hypertension and the 
effectiveness of treatment. Echocardiography measure­
ments were performed according to American Society 
of Echocardiography guidelines [22]. To standardize 
the left ventricular mass to height, left ventricular 
mass index (LVMI) was calculated according to the 
de Simone formula [23]. Left ventricular hypertrophy 
(LVH) was defined as an LVMI value above the 95th 
percentile for age­ and sex­based reference data [24].
Carotid-intima media thickness (cIMT) and 
wall cross sectional area of carotid arteries 
(WCSA) measurements
cIMT was evaluated by ultrasound, and SD of 
normal values for cIMT was obtained according 
to the methodology described previously [25, 26]. 
Mean WCSA was calculated from the equation: 
WCSA = π (dD/2+IMT)2−π(dD/2)2, where dD is 
the mean diastolic diameter [25].
Laboratory investigations
The following metabolic cardiovascular risk fac­
tors were assessed at diagnosis: plasma glucose level, 
lipid profile and serum uric acid. Blood samples were 
taken after 12 hours of fasting. The plasma glucose 
level was measured by a Dimension analyser. 
Definition of obesity and metabolic syndrome 
(MS)
Obesity was diagnosed according to the Interna­
tional Obesity Task Force recommendations [27]. 
MS was defined according to the International Dia­
betes Federation Consensus on MS in children [28]. 
Waist circumference (WC) was referred to Polish 
reference values [29]. 
Statistical analysis
The anthropometrical indices, IMT, WCSA, 
LVMI and PWV values were expressed as absolute 
values and SDS values according to the referential 
normative values published recently [26, 30]. The 
homogeneity of variance was checked with the Sha­
piro­Wilk test. Continuous variables with a normal 
distribution were compared using the Student t test 
for independent variables. Continuous values with 
abnormal distribution were compared using the Wil­
coxon test. Variables with normal distribution were 
presented as mean and SD values, whereas variables 
with abnormal distribution were presented as me­
dian and range values between the 5th and 95th 
percentiles. The correlation analysis was performed 
using Spearman test for abnormal distribution. Va­
riables with significant correlation including changes 
in anthropometrical parameters and changes in BP 
and metabolic parameters were then included in the 
step­wise multiple regression analysis. P values < 0.05 
were considered statistically significant, and values 
between 0.05 and 0.1 were considered as demonstra­
ting trend toward significance.
Results
Of 95 patients (pts) referred with elevated BP 
who underwent full diagnostic process, normoten­
sion (white coat hypertension) was diagnosed in 32, 
prehypertension in 12 , ambulatory hypertension in 
7 and severe ambulatory hypertension in 44 pts. MS 
was diagnosed in 9 pts (9%) (table I). 
The comparison of patients divided into four gro­
ups according to BP status revealed that only patients 
with severe ambulatory hypertension had significan­
tly greater CBP and AugPress compared to other 
groups. However, all groups did not differ regarding 
PWV (table II).
PWV correlated with uric acid (p = 0.001; r = 
0.357) and LDL­cholesterol (p = 0.01; r = 0.242), 
but not with markers of target organ damage (fig. 1, 
fig. 2).
AugPress and AugIndex correlated with triglyceri­
des concentrations (p = 0.003; r = 0.307; p = 0.002; 
r = 0.319) (fig. 3, fig. 4).
AugPress and AugIndex correlated with body mass 
index SDS values (BMI­SDS) (p = 0.014; r = 0.274 
and p = 0.007; r = 0.303 respectively) and PWV­SDS 
correlated not only with BMI­SDS (p = 0.001; 
r = 0.357) but also with WC­SDS (p = 0.004; 
r = 0.350).
LVH was found in 23 pts (24%) and subclinical 
arterial injury assessed as cIMT > 2 SDS in 32 pts 
(33%). WCSA > 2 SDS was noticed in 30 pts (31%).
24h ABPM systolic (24h SBP), diastolic (24h 
DBP) and mean (24h MAP) blood pressure, Au­
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Table I. Characteristic of patient group (n = 95, girls — 23) 
Tabela I. Charakterystyka grupy pacjentów (n = 95, 23 
dziewczynki)
Age (years) 15.3 ± 2.0
Height [cm] 170.3 ± 11.1
Weight [kg]   73.3 ± 15.5
BMI [kg/m2] 25.1 ± 3.8
BMI-SDS   1.24 ± 0.80
WC [cm]   81.7 ± 10.3
WC-SDS   1.20 ± 0.87
Classification of hyperten-
sion based on ABPM
Normal blood pressure — 32
Prehypertension — 12
Ambulatory blood pressure — 7
Severe ambulatory blood pressure — 
44 pts
ABPM 24h SBP [mm Hg]                        129 ± 9
ABPM 24h DBP [mm Hg] 73 ± 7
ABPM 24h MAP [mm Hg] 92 ± 6
ABPM heart rate   77 ± 11
cIMT [mm]   0.47 ± 0.04
cIMT-SDS   1.66 ± 0.92
cIMT > 2 SDS 32 pts (33%)
LVMI [g/m2,7] 35 ± 8
LVH 23 pts (24%)
PWV [m/s]   5.6 ± 0.6
PWV-SDS   1.43 ± 1.40
AugPress [mm Hg]   4 ± 3
AugIndex [mm Hg]   8 ± 5
CO [l/min]   6.01 ± 1.72
CI [l/min/m2]   3.29 ± 1.05
Cholesterol [mg/dl] 160 ± 32
Triglycerides [mg/dl] 101 ± 42
HDL-cholesterol [mg/dl]   50 ± 10
LDL-cholesterol [mg/dl]   90 ± 27
Uric acid [mg/dl]   5.7 ± 1.4
Fasting glucose [mg/dl] 89 ± 6
Metabolic syndrome 9 pts (9%)
BMI — body mass index; WC — waist circumference; ABPM — ambulatory blood pressure 
monitoring; 24h — 24 hours; SBP — systolic blood pressure; DBP — diastolic blood pressure; 
MAP — mean arterial pressure; HR — heart ratio; cIMT — carotid intima-media thickness; LVMI 
— left ventricular mass index; LVH — left ventricular hypertrophy; PWV — pulse wave velocity; 
AugPress — augmentation pressure; AugIndex — augmentation index; CO — cardiac output; 
CI — cardiac index; LDL — low density lipoprotein; HDL — high density lipoprotein
gIndex, AugPress and CBP correlated with LVMI 
(table III).
Patients with LVH had significantly greater 24h 
SBP, 24h DBP, 24h MAP and tendency to the greater 
AugPress than pts without LVH (table IV). There 
were no differences in PWV, and CBP between pa­
tients with LVH or without LVH. 
There were no differences in PWV and arterial 
stiffness markers between patients with arterial injury 
and those with normal cIMT and WCSA.
The stepwise regression analysis revealed that 
only AugIndex and 24h SBP predicted LVMI 
(R2 = 0.095; B = 0.308; p = 0.006 and R2 = 0,142; 
AugIndex : B = 0.280; p = 0.011; ABPM 24h SBP: 
B = 0.218; p = 0.047 respectively).
Discussion
Although the majority of studies related to arterial 
stiffness focused on PWV, which has been consid­
ered the most accurate non­invasive assessment of 
arterial stiffness and predictor of cardiovascular out­
comes, in our study we did not find any differences 
in PWV between patients with different BP status. 
In comparison, in adults PWV gradually increases as 
a function of BP classification. Furthermore, some 
reports have shown that subjects having elevated BP 
in childhood are at higher risk of increased arterial 
stiffness in adulthood [31]. The lack of changes in 
PWV in our children with different BP status may be 
partially explained by the young age and early phase 
of hypertensive disease. Although an increasing num­
ber of data have focused on PWV in adults, only 
a few studies have specifically concerning the relation­
ship between PWV and BP level in children [32, 33]. 
Moreover, recently published data evaluated PWV 
in healthy children and adolescents, indicated on 
gender, racial and age related differences in PWV, 
but findings regarding BP were inconclusive [32, 
34–38]. Thus, some authors suggest, that although 
PWV might be a more sensitive marker of arterial 
alteration and cardiovascular risk in older individu­
als, CBP and AugIndex may be better predictors in 
younger individuals [39, 40].
Moreover, the presence of increased PWV in 
young population, may indicate on the premature 
arterial stiffness as a consequence of an early vascular 
ageing [41].
Because CBP tends to be more closely associated 
with intermediate markers of cardiovascular events 
than brachial BP, classification of cardiovascular risk 
on the basis of CBP would appear to be important. 
In our study we divided patients according to BP 
strata and we found that only patients with severe 
ambulatory hypertension had significantly greater 
CBP and AugPress compared to other groups. 
CBP is typically affected by both a forward pulse 
wave, generated during left ventricular contraction 
and a reflected wave raised from arterial crotch. In 
healthy people the reflected wave reaches ascending 
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Table II. Anthropometrical and hemodynamic data compared with the category of hypertension 
Tabela II. Dane antropometryczne i hemodynamiczne w grupach pacjentów określonych na podstawie wartości ciśnienia 
tętniczego
Variable Normal blood 
pressure/White coat 
hypertension
N = 32 pts
Prehypertension
N = 12 pts
Ambulatory blood 
pressure
N = 7 pts
Severe ambulatory 
blood pressure
N = 44 pts
p
        Mean ± SD             Mean ± SD        Mean ± SD        Mean ± SD P
PWV [m/s]    5.7 ± 0.71   5.5 ± 0.6   5.6 ± 0.4     5.6 ± 0.65 n.s.
PWV-SDS  1.4 ± 1.4   1.36 ± 1.13 1.32 ± 0.7 1.45 ± 1.5 n.s.
CBP [mm Hg]   112 ± 7.1*    112 ± 10.2  114 ± 9.3      118 ± 10.1* 0.04
AoPP [mm Hg] 46 ± 6 46 ± 9 49 ± 9 51 ± 9 n.s.
AugPress [mm Hg]     3.4 ± 1.7*       3.0 ± 2.1**   3.8 ± 2.6           5.0 ± 3.2*. ** *0.04
**0.08
AugIndex (%)    7.2 ± 3.1    6.5 ± 4.3   7.5 ± 4.4   9.5 ± 5.3 n.s.
PWV — pulse wave velocity; CBP — central blood pressure; AoPP — aortic pulse pressure; AugPress — augmentation pressure; AugIndex — augmentation index
Figure 1. The correlation between pulse wave velocity (PWV) and 
LDL-cholesterol concentrations
Rycina 1. Korelacja między prędkością fali tętna (PWV) a stęże-
niem cholesterolu LDL we krwi
Figure 2. The correlation between pulse wave velocity (PWV) and 
uric acid (UA) concentrations
Rycina 2. Korelacja między prędkością fali tętna (PWV) a stęże-
niem kwasu moczowego we krwi
aorta during diastole and therefore does not signifi­
cantly augment central systolic BP. However, when 
arteries become stiffened the reflected wave returns 
earlier. This causes an augmentation of the forward 
wave and an increase in the systolic pressure [35, 39]. 
In this manner an increased AugPress and CBP in 
patients who had higher values of BP may indicate 
on the beginning of vascular stiffness.
In many studies the early markers of arterial 
stiffness, such as AugIndex, AugPress and elevated 
CBP have been shown as the main predictors of ad­
verse cardiovascular events and target organ damage 
[42–50]. Also in hypertensive adolescents and young 
adults increased arterial stiffness is associated with 
LVH independently of traditional cardiovascular risk 
factors [51]. 
We found that AugIndex, AugPress and CBP, but 
also ABPM values of BP correlated with LVH, but 
not with arterial injury markers. Patients with LVH 
had significantly higher 24h systolic, diastolic and 
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Table III. Correlations between LVMI and independent 
variables 
Tabela III. Korelacje między wskaźnikiem masy lewej ko-
mory serca (LVMI) a innymi parametrami hemodynamicz-
nymi (ujęto wyłącznie korelacje istotne statystycznie)
LVMI 
AugPress P = 0.02; r = 0.259 
AugIndex P = 0.03; r = 0.242 
CBP P = 0,03; r = 0.233
24h SBP P = 0.01; r = 0.262
24h DBP P = 0.02; r = 0.291
24h MAP P = 0.02; r = 0.295
AugPress — augmentation pressure; AugIndex — augmentation index; CBP — central 
blood pressure; 24h — 24 hours; SBP — systolic blood pressure; DBP — diastolic blood 
pressure; MAP — mean arterial pressure
Figure 3. The correlation between augmentation pressure and tri-
glycerides (TTG) concentrations
Rycina 3. Korelacja między ciśnieniem augmentacji (AugPress)  
a stężeniem trójglicerydów we krwi
Figure 4. The correlation between augmentation index (AugIndex) 
and triglycerides (TTG) concentrations
Rycina 4. Korelacja między wskaźnikiem augmentacji (AugIndex)  
a stężeniem trójglicerydów we krwi
Table IV. The comparison of patients with and without LVH 
Tabela IV. Porównanie grup pacjentów z przerostem lewej 
komory serca (LVH) i bez przerostu
LVMI > 95cc 
N = 23 pts
LVMI < 95cc 
N = 72 pts
Mean ± SD Mean ± SD p
ABPM 24h SBP [mm Hg]     135 ± 10    128 ± 9 0.01
ABPM 24h DBP [mm Hg]       77 ± 7   73 ± 7 0.026
ABPM 24h MAP [m m 
Hg]
      95 ± 6   91 ± 6 0.018
ABPM 24h PP [mm Hg]       60 ± 14       55 ± 7 0.1
PWV [m/s]    5.58 ± 0.59     5.61 ± 0.62 n.s.
PWV-SDS    1.47 ± 1.43     1.35 ± 1.25 n.s.
CBP [mm Hg]  117 ± 11     114 ± 8 n.s.
AoPP [mm Hg]    51 ± 10       48 ± 8 n.s.
AugPress [mm Hg]    4 ± 3         3 ± 2 0.07
AugIndex (%)     9.33 ± 5.02     7.53 ± 4.39 n.s.
ABPM — ambulatory blood pressure monitoring; 24h — 24 hours; SBP — systolic blood 
pressure; DBP — diastolic blood pressure; MAP — mean arterial pressure; PP — pulse 
pressure; PWV — pulse wave velocity; CBP — central blood pressure; AoPP — aortic pulse 
pressure; AugPress — augmentation pressure; AugIndex — augmentation index; LVMI  
— left ventricular mass index
mean BP and tendency to higher AugPress than 
patients without LVH. However, there were no dif­
ferences in PWV and CBP between patients with 
LVH or without LVH. It confirms that some abnor­
malities in arterial wall properties can be identified at 
the early stages of hypertension and influence TOD, 
but advanced arterial stiffness expressed as increased 
PWV develop on more advanced stages of hyperten­
sive disease.
Recently, it has been shown that adults and chil­
dren with obesity have increased aortic stiffness, 
independent of BP level, ethnicity, and age. An in­
creased aortic stiffness has been shown to be more 
related to body fat deposition and visceral adipo­
sity than to increased BMI [52–54]. On the other 
hand, some data indicated that total trunk fat has 
been found to be associated adversely with PWV 
[33, 55]. In our study AugPress and AugIndex 
correlated with BMI­SDS, and PWV­SDS correla­
nadciśnienie tętnicze rok 2014, tom 18, nr 4
200 www.nt.viamedica.pl
ted positively with BMI­SDS and with WC­SDS. 
Several factors have been proposed to explain the 
increased stiffness observed in individuals with 
visceral obesity. Impaired mechanisms of endothe­
lium­dependent flow dilation and nitrite oxide di­
sorders are suggested as well as sympathetic system 
activation. Moreover, the reduced arterial elasticity 
may be the consequence of metabolic abnorma­
lities with hyperglycaemia and insulin disorders 
leading to the development of advanced glycation 
end products. Non­enzymatic glycosylation of the 
matrix proteins of arterial vessels may amplified 
the production of collagen fibres, which in turn 
are responsible for increased arterial stiffness and 
hypertension [56, 57]. There is some evidence that 
also children with worse cardiometabolic profi­
le and prediabetes are characterized by increased 
arterial stiffness [58, 59]. Metabolic syndrome in 
childhood predicted the increased arterial stiffness 
in adulthood, and recovery from childhood meta­
bolic abnormalities was associated with decreased 
arterial PWV in adulthood [60]. In our study 
we did not find any associations between arterial 
stiffness markers and insulin sensitivity/resistance 
markers, but we found positive correlations with 
other metabolic risk factors. There was a positive 
correlation of PWV with uric acid and LDL­cho­
lesterol and between AugPress and AugIndex with 
triglycerides concentrations. It may suggest the 
important role of metabolic abnormalities at the 
early stages of cardiovascular disease.
Limitations and strengths of the study
The limitations of the study include a relatively 
narrow age range of participants, which made it dif­
ficult to determine whether parameters of arterial 
stiffness changed with age. Also, due to cross­sectio­
nal study it was unfeasible to observe any changes in 
arterial stiffness over time. 
Strength of our study was the large number of 
young participants at the early stage of disease, de­
tailed biochemical and hemodynamic investigations 
and assessment of intermediate phenotype. Moreo­
ver, our study was able to compare commonly used 
peripheral BP measurements to non­invasive CBP 
pressure and arterial stiffness markers as predictors 
of TOD.
Conclusions
CBP and AugPress assessed non­invasively with 
oscillometric method correlated with markers of 
hypertensive TOD. Because the role of CBP and 
24h ABPM BP as predictors of TOD was similar, 
non­invasive assessment of arterial stiffness offers 
a useful tool in the clinical evaluation of blood 
pressure. 
Summary
Background Arterial stiffness measured as pulse 
wave velocity is regarded as one of the markers of 
target organ damage in hypertensive adults. Pulse 
wave analysis adds the information about central 
blood pressure, backward pulse wave, cardiac output 
and total peripheral resistance. However, there are 
no data regarding the usefulness of measurements of 
pulse wave velocity, central blood pressure, augmen­
tation pressure and augmentation index in assess­
ment of risk of target organ damage in hypertensive 
children. The aim of the study was to estimate the 
relationship of pulse wave velocity and pulse wave 
analysis with established markers of target organ da­
mage (left ventricular mass index, carotid intima­
media thickness, carotid wall cross sectional area) in 
children with untreated primary hypertension.
Material and methods Ninety­five patients (14.9 ± 
2.5 years; 23 girls) referred as newly diagnosed pri­
mary hypertension were included in the study. Pulse 
wave velocity and pulse wave analysis were measured 
by oscillometric method using Vicorder device. Pulse 
wave velocity and carotid intima­media thickness 
were expressed as absolute and SDS values regarding 
recently published normative values.
Results In 95 patients referred with elevated blood 
pressure and who underwent full diagnostic process, 
normotension was diagnosed in 32, prehypertension 
in 12, ambulatory hypertension in 7 and severe am­
bulatory hypertension in 44 patients. Patients with 
left ventricular hypertrophy had significantly greater 
24h systolic, diastolic and mean blood pressure and 
tendency to the greater augmentation pressure than 
patients without left ventricular hypertrophy. There 
were no differences in pulse wave velocity and central 
blood pressure between patients with left ventricular 
hypertrophy and/or carotid intima­media thickness 
> 2SDS and patients without target organ damage. 
The comparison of patients divided into four gro­
ups according to blood pressure status revealed that 
only patients with severe ambulatory hypertension 
had significantly greater augmentation pressure and 
central blood pressure compared with other gro­
ups. However, groups did not differ regarding pulse 
wave velocity. Pulse wave velocity correlated with 
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uric acid (p = 0.001; r = 0.357) and LDL­choleste­
rol (p = 0.01; r = 0.242), but not with target organ 
damage. Augmentation pressure and augmenta­
tion index correlated with triglycerides (p = 0.003; 
r = 0.307; p = 0.002; r = 0.319). The stepwise re­
gression analysis revealed that only augmentation 
index and 24h systolic blood pressure predicted 
left ventricular mass index (R2 = 0.095; B = 0.308; 
p = 0.006 and R2 = 0,142; Augmentation Index: 
B = 0.280; p = 0.011; ABPM SBP: B = 0.218; 
p = 0.047 respectively).
Conclusions In children with primary hyperten­
sion, blood pressure status, central blood pressure, 
augmentation pressure and augmentation index, but 
not pulse wave velocity, correlate with left ventricular 
hypertrophy. However, pulse wave velocity correlates 
with biochemical risk factors of target organ damage. 
The lack of direct association between pulse wave ve­
locity and target organ damage may be due relatively 
modest elevation of blood pressure and short dura­
tion of hypertensive disease in children with primary 
hypertension.
key words: primary hypertension, metabolic 
syndrome, arterial stiffness, pulse wave velocity, 
central blood pressure, target organ damage
Arterial Hypertension 2014, vol. 18, no 4, pages: 194–203
References
1. Laurent S., Boutouyrie P., Asmar R. et al. Aortic stiffness is an 
independent predictor of all­cause and cardiovascular mortality 
in hypertensive patients. Hypertension 2001; 37: 1236–1241.
2. Boutouyrie P., Tropeano A.I., Asmar R. et al. Aortic stiff­
ness is an independent predictor of primary coronary events 
in hypertensive patients: a longitudinal study. Hypertension 
2002; 39: 10–15. 
3. Laurent S., Katsahian S., Fassot C. et al. Aortic stiffness is an 
independent predictor of fatal stroke in essential hypertension. 
Stroke 2003; 34: 1203–1206. 
4. Roman M.J., Devereux R.B., Kizer J.R. et al. Central pressure 
more strongly relates to vascular disease and outcome than does 
brachial pressure: the Strong Heart Study. Hypertension 2007; 
50: 197–203. 
5. Jankowski P., Kawecka­Jaszcz K., Czarnecka D. et al. Aortic 
Blood Pressure and Survival Study Group. Pulsatile but not 
steady component of blood pressure predicts cardiovascular 
events in coronary patients. Hypertension 2008; 51: 848–855. 
6. Vlachopoulos C., Aznaouridis K., O’Rourke M.F., Safar 
M.E., Baou K., Stefanadis C. Prediction of cardiovascular 
events and all­cause mortality with central haemodynamics: a 
systematic review and meta­analysis. Eur. Heart J. 2010; 31: 
1865–1871. 
7. Wang K.L., Cheng H.M., Chuang S.Y. et al. Central or 
peripheral systolic or pulse pressure: which best relates to target 
organs and future mortality? J. Hypertens. 2009; 27: 461–467. 
8. Mitchell G.F., Hwang S.J., Vasan R.S. et al. Arterial stiffness 
and cardiovascular events: the Framingham Heart Study. Cir­
culation 2010; 121: 505–511.
9. Varol E., Ozaydin M. The predictive value of aortic stiffness 
for asymptomatic coronary artery disease in a stroke/transient 
ischemic attack: role of hypertension and antihypertensive 
drugs. Int. J. Stroke 2014; 9: E44.
10. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., 
London G.M. Impact of aortic stiffness on survival in end­stage 
renal disease. Circulation 1999; 99: 2434–2439.
11. Narayan O Davies J.E., Hughes A.D. et al. Central aortic 
reservoir­wave analysis improves prediction of cardiovascular 
events in elderly hypertensives. Hypertension 2015; 65: 629–635.
12. Covic A., Mardare N., Gusbeth­Tatomir P., Prisada O., 
Sascau R., Goldsmith D.J. Arterial wave reflections and mor­
tality in haemodialysis patients — only relevant in elderly, 
cardiovascularly compromised? Nephrol. Dial. Transplant. 
2006; 21: 2859–2866.
13. Mancia G., De Backer G., Dominiczak A. et al. Mana­
gement of Arterial Hypertension of the European Society of 
Hypertension; European Society of Cardiology 2007 Guidelines 
for the Management of Arterial Hypertension: The Task Force 
for the Management of Arterial Hypertension of the European 
Society of Hypertension (ESH) and of the European Society of 
Cardiology (ESC). J. Hypertens. 2007; 25: 1105–1187.
14. Mancia G., Fagard R., Narkiewicz K. et al. Task Force 
Members.2013 ESH/ESC Guidelines for the management of 
arterial hypertension: the Task Force for the management of 
arterial hypertension of the European Society of Hypertension 
(ESH) and of the European Society of Cardiology (ESC). 
J. Hypertens. 2013; 31: 1281–357.
15. National High Blood Pressure Education Program Working 
Group on High Blood Pressure in Children and Adolescents. 
The fourth report on diagnosis, evaluation and treatment of 
high blood pressure in children and adolescents. Pediatrics 
2004; 114: 555–576.
16. Lurbe E., Cifkova R., Cruickshank J.K. et al. European 
Society of Hypertension. Management of high blood pressure 
in children and adolescents: recommendations of the European 
Society of Hypertension. J. Hypertens. 2009; 27: 1719–1742.
17. Urbina E., Alpert B., Flynn J. et al. American Heart Asso­
ciation Atherosclerosis, Hypertension, and Obesity in Youth 
Committee. Ambulatory blood pressure monitoring in children 
and adolescents: recommendations for standard assessment: 
a scientific statement from the American Heart Association 
Atherosclerosis, Hypertension and Obesity in Youth Committee 
of the Council on Cardiovascular Disease in the Young and 
the Council for High Blood Pressure Research. Hypertension 
2008; 52: 433–451.
18. Flynn J.T., Daniels S.R., Hayman L.L. et al. American 
Heart Association Atherosclerosis, Hypertension and Obesity 
in Youth Committee of the Council on Cardiovascular Disease 
in the Young. Update: ambulatory blood pressure monitoring in 
children and adolescents: a scientific statement from the Ame­
rican Heart Association. Hypertension.. 2014; 63: 1116–1135.
19. Fischer D.C., Schreiver C., Heimhalt M., Noerenberg A., 
Haffner D. Pediatric reference values of carotid­femoral pulse 
wave velocity determined with an oscillometric device. J. Hy­
pertens. 2012; 30: 2159–2167. 
20. Van Bortel L.M., Laurent S., Boutouyrie P. et al. Artery 
Society; European Society of Hypertension Working Group 
on Vascular Structure and Function; European Network for 
Noninvasive Investigation of Large Arteries. Expert consensus 
document on the measurement of aortic stiffness in daily prac­
tice using carotid­femoral pulse wave velocity. J. Hypertens. 
2012; 30: 445–448.
nadciśnienie tętnicze rok 2014, tom 18, nr 4
202 www.nt.viamedica.pl
21. Kracht D., Shroff R., Baig S. et al. Validating a new oscil­
lometric device for aortic pulse wave velocity measurements 
in children and adolescents. Am. J. Hypertens. 2011; 24: 
1294–1299.
22. Nagueh S.F., Appleton C.P., Gillebert T.C. et al. Recom­
mendations for the evaluation of left ventricular diastolic 
function by echocardiography. J. Am. Soc. Echocardiogr. 2009; 
22: 107–133.
23. De Simone G., Deveraux R.B., Daniels S.R., Koren M.J., 
Meyer R.A., Laragh J.H. Effect of growth on variability of left 
ventricular mass: assessment of allometric signals in adults and 
children and their capacity to predict cardiovascular risk. J. Am. 
Coll. Cardiol. 1995; 25: 1056–1062.
24. Khoury P.R., Mitsnefes M., Daniels S.R., Kimball T.R. 
Age­specific reference intervals for indexed left ventricular mass 
in children. J. Am. Soc. Echocardiogr. 2009; 22: 709–714.
25. Jourdan C., Wuhl E., Litwin M. et al. Normative values 
of intima­media thickness and distensibility of large arteries 
in healthy adolescents. J. Hypertens. 2005; 23: 1707–1715.
26. Doyon A., Kracht D., Bayazit A.K. et al. 4C Study Consor­
tium. Carotid artery intima­media thickness and distensibility 
in children and adolescents: reference values and role of body 
dimensions. Hypertension 2013; 62: 550–556.
27. Cole T.J., Bellizzi M.C., Flegal K.M., Dietz W.H. Esta­
blishing a standard definition for child overweight and obesity 
worldwide: international study. BMJ 2000; 320: 1240–1243.
28. Zimmet P., Alberti K., George M.M. et al. The metabolic 
syndrome in children and adolescents — an IDF consensus 
report. Pediatric Diabetes. 2007; 8: 299–306.
29. Kułaga Z., Litwin M., Zajączkowska M.M. et al. Compa­
rison of waist and hip circumferences ranges in children and 
adolescents in Poland 7–18 y of age with cardiovascular risk 
thresholds – initial results of OLAF project (PL0080). Standardy 
Medyczne 2008; 5: 473–485.
30. Elmenhorst J., Hulpke­Wette M., Barta C., Dalla Pozza R., 
Springer S., Oberhoffer R. Percentiles for central blood pressure 
and pulse wave velocity in children and adolescents recorded 
with an oscillometric device. Atherosclerosis 2015; 238: 9–16.
31. Aatola H., Magnussen C.G., Koivistoinen T. et al. Simplified 
definitions of elevated pediatric blood pressure and high adult 
arterial stiffness. Pediatrics 2013; 132: e70–76.
32. Urbina E.M., Khoury P.R., McCoy C., Daniels S.R., 
Kimball T.R., Dolan L.M. Cardiac and vascular consequences 
of pre­hypertension in youth. J Clin Hypertens (Greenwich). 
2011; 13: 332–342. 
33. Urbina E.M., Kimball T.R., Khoury P.R., Daniels S.R., 
Dolan L.M. Increased arterial stiffness is found in adolescents 
with obesity or obesity­related type 2 diabetes mellitus. J. Hy­
pertens. 2010; 28: 1692–1698.
34. Hayward C.S., Kelly R.P. Gender­related differences in the 
central arterial pressure waveform. J. Am. Coll. Cardiol. 1997; 
30: 1863–1871.
35. Mitchell G.F., Parise H., Benjamin E.J. et al. Changes in ar­
terial stiffness and wave reflection with advancing age in healthy 
men and women: the Framingham Heart Study. Hypertension 
2004; 43: 1239–1245.
36. Urbina E.M., Williams R.V., Alpert B.S. et al. American 
Heart Association Atherosclerosis Hypertension Obesity in 
Youth Committee of the Council on Cardiovascular Disease in 
the Young. Non­invasive assessment of subclinical atherosclero­
sis in children and adolescents: recommendations for standard 
assessment for clinical research: a scientific statement from the 
American Heart Association. Hypertension 2009; 54: 919–950.
37. Collins R.T., Somes G.W., Alpert B.S. Differences in 
arterial compliance among normotensive adolescent groups: 
Collins arterial compliance in adolescents. Pediatr. Cardiol. 
2008; 29: 929–934.
38. Sakuragi S., Abhayaratna K., Gravenmaker K.J. et al. In­
fluence of adiposity and physical activity on arterial stiffness in 
healthy children: the lifestyle of our kids study. Hypertension 
2009; 53: 611–616.
39. McEniery C.M., Yasmin, Hall I.R., Qasem A., Wilkinson 
I.B., Cockcroft J.R. ACCT Investigators. Normal vascular 
aging: differential effects on wave reflection and aortic pulse 
wave velocity: the Anglo­Cardiff Collaborative Trial (ACCT). 
J. Am. Coll. Cardiol. 2005; 46: 1753–1760.
40. Koivistoinen T., Virtanen M., Hutri­Kähönen N. et al. 
Arterial pulse wave velocity in relation to carotid intima­media 
thickness, brachial flow­mediated dilation and carotid artery 
distensibility: the Cardiovascular Risk in Young Finns Study and 
the Health 2000 Survey. Atherosclerosis 2012; 220: 387–393.
41. Kotsis V., Stabouli S., Karafillis I. et al. Arterial stiffness and 24 
h ambulatory blood pressure monitoring in young healthy volun­
teers: the early vascular ageing Aristotle University Thessaloniki 
Study (EVA­ARIS Study). Atherosclerosis 2011; 219: 194–199.
42. Shimizu M., Kario K. Review: Role of the Augmentation 
Index in Hypertension. Therapeutic Advances in Cardiovascular 
Disease 2008; 2: 25–35.
43. Kelly R., Hayward C., Avolio A., O’Rourke M. Noninvasive 
Determination of Age­related Changes in the Human Arterial 
Pulse. Circulation 1989; 80: 1652–1659.
44. Palatini P., Casiglia E., Gąsowski J. et al. Arterial stiffness, 
central hemodynamics, and cardiovascular risk in hypertension. 
Vasc. Health Risk. Manag. 2011; 7: 725–739.
45. Weber T., Auer J., O’Rourke M.F. et al. Increased Arterial 
Wave Reflections Predict Severe Cardiovascular Events in 
Patients Undergoing Percutaneous Coronary Interventions. 
European Heart Journal 2005; 26: 2657–2663.
46.  Chirinos J.A., Zambrano J.P., Chakko S. et al. Aortic 
Pressure Augmentation Predicts Adverse Cardiovascular Events 
in Patients With Established Coronary Artery Disease. Hyper­
tension 2005; 45: 980–985. 
47. Saba P.S., Roman M.J., Pini R., Spitzer M., Ganau A., 
Devereux R.B. Relation of Arterial Pressure Waveform to Left 
Ventricular and Carotid Anatomy in Normotensive Subjects. 
J. Am. Coll. Cardiol. 1993; 22: 1873–1880. 
48. Hashimoto J., Watabe D., Hatanaka R. et al. Enhanced 
Radial Late Systolic Pressure Augmentation in Hypertensive 
Patients With Left Ventricular Hypertrophy. Am. J. Hypertens. 
2006; 19: 27–32.
49. Roman M.J., Okin P.M., Kizer J.R., Lee E.T., Howard B.V., 
Devereux R.B. Relations of central and brachial blood pressure 
to left ventricular hypertrophy and geometry: the Strong Heart 
Study. J. Hypertens. 2010; 28: 384–388.
50. Jankowski P., Kawecka­Jaszcz K., Czarnecka D. et al. Ascen­
ding aortic, but not brachial blood pressure­derived indices 
are related to coronary atherosclerosis. Atherosclerosis 2004; 
176: 151–155.
51. Urbina E.M., Dolan L.M., McCoy C.E., Khoury P.R., Da­
niels S.R., Kimball T.R. Relationship between elevated arterial 
stiffness and increased left ventricular mass in adolescents and 
young adults. J. Pediatr. 2011; 158: 715–721.
52. Wohlfahrt P., Somers V.K., Sochor O., Kullo I., Jean N., 
Lopez­Jimenez F. Influence of Body Fatness Distribution and 
Total Lean Mass on Aortic Stiffness in Nonobese Individuals. 
Am. J. Hypertens. 2015; 28: 401–408.
Anna Niemirska i wsp. Pulse wave velocity and pulse wave analysis in children with primary hypertension
203www.nt.viamedica.pl
53. Wildman R.P., Mackey R.H., Bostom A., Thompson T., 
Sutton­Tyrrell K. Measures of obesity are associated with 
vascular stiffness in young and older adults. Hypertension 
2003; 42: 468–473.
54. Tounian P., Aggoun Y., Dubern B. et al. Presence of incre­
ased stiffness of the common carotid artery and endothelial 
dysfunction in severely obese children: A prospective study. 
Lancet 2001; 358: 1400–1404.
55. Urbina E.M., Gao Z., Khoury P.R., Martin L.J., Dolan L.M. 
Insulin resistance and arterial stiffness in healthy adolescents and 
young adults. Diabetologia 2012; 55: 625–631.
56. Safar M.E., Balkau B., Lange C. et al. Hypertension and 
vascular dynamics in men and women with metabolic syndro­
me. J. Am. Coll. Cardiol. 2013; 61: 12–19.
57. Safar M.E., Czernichow S., Blacher J. Obesity, arterial 
stiffness, and cardiovascular risk. J. Am. Soc. Nephrol. 2006; 
17 (4 Suppl. 2): S109–111.
58. Shah A.S., Gao Z., Urbina E.M., Kimball T.R., Dolan L.M. 
Prediabetes: the effects on arterial thickness and stiffness in 
obese youth. J. Clin. Endocrinol. Metab. 2014; 99: 1037–1043.
59. Urbina E.M., Kimball T.R., McCoy C.E., Khoury P.R., 
Daniels S.R., Dolan L.M. Youth with obesity and obesity­related 
type 2 diabetes mellitus demonstrate abnormalities in carotid 
structure and function. Circulation 2009; 119: 2913–2919.
60. Koivistoinen T., Hutri­Kähönen N., Juonala M. et al. Me­
tabolic syndrome in childhood and increased arterial stiffness 
in adulthood: the Cardiovascular Risk In Young Finns Study. 
Ann. Med. 2011; 43: 312–319.
